- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
已发现中线卖出信号。
- 长期趋势：
已有7家主力机构披露2025-06-30报告期持股数据，持仓量总计1.10亿股，占流通A股46.01%
- 波段诊断：
-
技术面诊股
诊断结果：5.9技术面打败了42%的股票
技术面评分前10的股票
近期的平均成本为12.30元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。已发现中线卖出信号。
平均成本
近期的平均成本为12.24元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.24","date":1761637936,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，明显跑赢行业平均水平。
[{"date":"2025.10.29","stock":"-0.49","trade":"-0.32","ind":"1.95"},{"date":"2025.10.28","stock":"0.98","trade":"-0.54","ind":"-0.44"},{"date":"2025.10.27","stock":"-0.25","trade":"-0.12","ind":"1.51"},{"date":"2025.10.24","stock":"-3.55","trade":"-0.63","ind":"2.02"},{"date":"2025.10.23","stock":"9.97","trade":"-0.36","ind":"0.22"},{"date":"2025.10.22","stock":"2.04","trade":"0.70","ind":"-0.62"},{"date":"2025.10.21","stock":"1.25","trade":"0.86","ind":"2.06"},{"date":"2025.10.20","stock":"-0.71","trade":"0.20","ind":"0.98"},{"date":"2025.10.17","stock":"-0.35","trade":"-0.94","ind":"-3.04"},{"date":"2025.10.16","stock":"0.62","trade":"0.75","ind":"-0.25"},{"date":"2025.10.15","stock":"0.72","trade":"1.37","ind":"1.73"},{"date":"2025.10.14","stock":"-0.54","trade":"0.32","ind":"-2.54"},{"date":"2025.10.13","stock":"-2.86","trade":"-0.86","ind":"-0.93"},{"date":"2025.10.10","stock":"-1.45","trade":"1.31","ind":"-2.70"},{"date":"2025.10.09","stock":"1.83","trade":"0.26","ind":"1.47"},{"date":"2025.09.30","stock":"-0.17","trade":"0.12","ind":"0.35"},{"date":"2025.09.29","stock":"-1.12","trade":"0.13","ind":"2.05"},{"date":"2025.09.26","stock":"-1.11","trade":"-0.51","ind":"-1.76"},{"date":"2025.09.25","stock":"-0.59","trade":"-0.70","ind":"0.67"},{"date":"2025.09.24","stock":"1.20","trade":"1.12","ind":"1.80"},{"date":"2025.09.23","stock":"-1.52","trade":"-1.40","ind":"-0.29"}]
启迪药业,深证成指,中药指数
压力支撑
该股压力位为12.26元，支撑位为12.10元。
[{"text":"\u538b\u529b\u4f4d","value":"12.26","date":1761667200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.10","date":1761667200,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。已发现中线卖出信号。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.9资金面打败了50%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：10月29日 16:10
| 机构今日流向(万元) | -818.06 | 机构5日流向(万元) | -7732.06 |
| 机构10日流向(万元) | -7373.36 | 机构20日流向(万元) | -8908.69 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加82.13万股，其中基金数没有增加，主力净减仓6家，暂未发现中长期投资价值。
截止2025-06-30，共7家主力机构（基金3家，一般法人4家），持仓量总计11012.73万股，占流通A股46.01%
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 2.16万股
减仓：1家 ，减持 0.72万股
新出现在主力名单中：2家 ，持有118.74万股
从主力名单中消失：8家 ，原持有38.05万股
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 2.16万股
减仓：1家 ，减持 0.72万股
新出现在主力名单中：2家 ，持有118.74万股
从主力名单中消失：8家 ，原持有38.05万股
消息面诊股
诊断结果：5.5消息面打败了7%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 最高大涨15倍，“易主”题材火了（附股）
2025-10-28 - 筹划控制权易主数量创纪录 产业协同资本赋能 重构上
2025-10-28 - 行业周报|中药指数涨0.77%, 跑输上证指数2.
2025-10-24 - 启迪药业10月23日涨停分析
2025-10-23 - 启迪药业：公司暂无海外业务或出口收入
2025-10-21 - “湖南医药第一股”启迪药业正式易主
2025-10-13 - 行业追踪|中医药市场（9月29日-10月5日）：综
2025-10-05 - 4100亿市场热浪不断！186个中成药国家药品标准
2025-09-29 - 行业追踪|中医药市场（9月22日-9月28日）：综
2025-10-02 - “湖南医药第一股”启迪药业控制权变更落地，恒昌医药
2025-09-25
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-24 |
| 一般消息 | 重大事项 | 关联交易 | 2025-09-23 |
| 一般消息 | 高管变动 | 因职业规划原因 | 2025-09-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-09-17 |
| 一般消息 | 高管变动 | 因工作变动 | 2025-08-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-27 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-08-13 |
| 利好 | 业绩预告 | 预计减亏 | 2025-07-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-03-28 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.3行业面打败了74%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.10.29","price":"1.95","value":"-0.32"},{"date":"2025.10.28","price":"-0.44","value":"-0.54"},{"date":"2025.10.27","price":"1.51","value":"-0.12"},{"date":"2025.10.24","price":"2.02","value":"-0.63"},{"date":"2025.10.23","price":"0.22","value":"-0.36"},{"date":"2025.10.22","price":"-0.62","value":"0.70"},{"date":"2025.10.21","price":"2.06","value":"0.86"},{"date":"2025.10.20","price":"0.98","value":"0.20"},{"date":"2025.10.17","price":"-3.04","value":"-0.94"},{"date":"2025.10.16","price":"-0.25","value":"0.75"},{"date":"2025.10.15","price":"1.73","value":"1.37"},{"date":"2025.10.14","price":"-2.54","value":"0.32"},{"date":"2025.10.13","price":"-0.93","value":"-0.86"},{"date":"2025.10.10","price":"-2.70","value":"1.31"},{"date":"2025.10.09","price":"1.47","value":"0.26"},{"date":"2025.09.30","price":"0.35","value":"0.12"},{"date":"2025.09.29","price":"2.05","value":"0.13"},{"date":"2025.09.26","price":"-1.76","value":"-0.51"},{"date":"2025.09.25","price":"0.67","value":"-0.70"},{"date":"2025.09.24","price":"1.80","value":"1.12"},{"date":"2025.09.23","price":"-0.29","value":"-1.40"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 35.53% | -2.75% | 5.4分 |
| 2 | 特一药业 | 26.61% | 9.52% | 6.0分 |
| 3 | 方盛制药 | 14.16% | 1.45% | 6.4分 |
| 4 | 吉林敖东 | 10.88% | 1.96% | 5.4分 |
| 5 | 以岭药业 | 10.76% | 3.33% | 6.2分 |
| 6 | 信邦制药 | 10.66% | -0.52% | 5.4分 |
| 8 | 粤万年青 | 8.04% | 1.30% | 5.4分 |
| 10 | 益盛药业 | 5.04% | 0.25% | 5.3分 |
| 12 | 羚锐制药 | 4.33% | 0.87% | 5.8分 |
| 14 | 陇神戎发 | 3.81% | -0.88% | 5.0分 |
| 16 | 新光药业 | 3.38% | -0.61% | 5.5分 |
| 18 | 华润三九 | 3.06% | 1.83% | 5.7分 |
| 20 | 华神科技 | 2.31% | -0.25% | 5.9分 |
| 22 | 佛慈制药 | 2.28% | -0.99% | 5.4分 |
| 24 | 桂林三金 | 2.11% | -0.73% | 5.5分 |
| 26 | 精华制药 | 1.79% | 0.00% | 5.5分 |
| 28 | 康恩贝 | 1.37% | -0.22% | 5.9分 |
| 30 | ST葫芦娃 | 0.99% | 1.78% | 5.4分 |
| 32 | 江中药业 | 0.66% | -1.06% | 4.8分 |
| 34 | 东阿阿胶 | 0.53% | -0.92% | 4.7分 |
| 36 | 珍宝岛 | 0.26% | -1.54% | 4.5分 |
| 38 | 亚宝药业 | -0.15% | -2.48% | 5.3分 |
| 40 | 天士力 | -0.77% | -3.27% | 5.2分 |
| 42 | 华森制药 | -1.02% | -3.17% | 5.1分 |
| 44 | 康美药业 | -1.45% | -0.49% | 5.4分 |
| 46 | 汉森制药 | -1.55% | -4.23% | 5.1分 |
| 48 | 步长制药 | -1.94% | -1.50% | 5.6分 |
| 50 | 仁和药业 | -2.06% | -0.16% | 5.4分 |
| 52 | 新天药业 | -2.28% | -0.37% | 5.0分 |
| 54 | 寿仙谷 | -2.90% | -1.16% | 5.1分 |
| 56 | 康缘药业 | -3.72% | -4.46% | 4.9分 |
| 58 | 健民集团 | -4.16% | -3.33% | 5.0分 |
| 60 | 奇正藏药 | -4.50% | -4.97% | 4.8分 |
| 62 | - | -5.17% | -2.98% | 分 |
| 64 | 恩威医药 | -5.85% | 2.11% | 5.6分 |
| 66 | 贵州三力 | -6.77% | -2.96% | 5.1分 |
| 68 | ST香雪 | -8.49% | -4.39% | 3.7分 |
| 70 | 振东制药 | -9.32% | -3.45% | 5.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 63/110 ， 46/110。
[{"date":"2025-06-30","value":"-2.91","vol":"3.94"},{"date":"2025-03-31","value":"-2.75","vol":"2.20"},{"date":"2024-12-31","value":"-18.98","vol":"4.81"},{"date":"2024-09-30","value":"-4.01","vol":"2.92"},{"date":"2024-06-30","value":"-3.29","vol":"1.58"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.91 | -2.75 | -18.98 | -4.01 | -3.29 |
| 行业(%) | 3.94 | 2.20 | 4.81 | 2.92 | 1.58 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"44.93","vol":"52.43"},{"date":"2025-03-31","value":"47.45","vol":"52.92"},{"date":"2024-12-31","value":"46.81","vol":"52.40"},{"date":"2024-09-30","value":"46.21","vol":"52.75"},{"date":"2024-06-30","value":"47.31","vol":"53.12"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
44.93 | 47.45 | 46.81 | 46.21 | 47.31 |
| 行业(%) | 52.43 | 52.92 | 52.40 | 52.75 | 53.12 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 28/110 ， 13/110。
[{"date":"2025-06-30","value":"-2.87","vol":"-6.98"},{"date":"2025-03-31","value":"-15.40","vol":"-6.63"},{"date":"2024-12-31","value":"-15.18","vol":"-6.97"},{"date":"2024-09-30","value":"-21.26","vol":"-4.57"},{"date":"2024-06-30","value":"-22.83","vol":"-4.39"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-2.87 | -15.40 | -15.18 | -21.26 | -22.83 |
| 行业(%) | -6.98 | -6.63 | -6.97 | -4.57 | -4.39 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"26.61","vol":"2.33"},{"date":"2025-03-31","value":"-96.23","vol":"-36.42"},{"date":"2024-12-31","value":"-596.98","vol":"-142.71"},{"date":"2024-09-30","value":"-542.52","vol":"63.06"},{"date":"2024-06-30","value":"-466.54","vol":"-13.80"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
26.61 | -96.23 | -596.98 | -542.52 | -466.54 |
| 行业(%) | 2.33 | -36.42 | -142.71 | 63.06 | -13.80 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 55/110 ， 55/110。
[{"date":"2025-06-30","value":"0.14","vol":"0.24"},{"date":"2025-03-31","value":"0.06","vol":"0.12"},{"date":"2024-12-31","value":"0.32","vol":"0.49"},{"date":"2024-09-30","value":"0.19","vol":"0.37"},{"date":"2024-06-30","value":"0.13","vol":"0.26"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.06 | 0.32 | 0.19 | 0.13 |
| 行业(次) | 0.24 | 0.12 | 0.49 | 0.37 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.62","vol":"1.17"},{"date":"2025-03-31","value":"0.27","vol":"0.60"},{"date":"2024-12-31","value":"1.43","vol":"2.40"},{"date":"2024-09-30","value":"0.84","vol":"1.79"},{"date":"2024-06-30","value":"0.56","vol":"1.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.62 | 0.27 | 1.43 | 0.84 | 0.56 |
| 行业(次) | 1.17 | 0.60 | 2.40 | 1.79 | 1.23 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/110 ， 56/110。
[{"date":"2025-06-30","value":"109.74","vol":"20.17"},{"date":"2025-03-31","value":"-82.48","vol":"0.38"},{"date":"2024-12-31","value":"2.74","vol":"15.45"},{"date":"2024-09-30","value":"2.60","vol":"6.15"},{"date":"2024-06-30","value":"78.14","vol":"11.77"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 109.74 | -82.48 | 2.74 | 2.60 | 78.14 |
| 行业 | 20.17 | 0.38 | 15.45 | 6.15 | 11.77 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.62","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.07","vol":"1.46"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.48","vol":"1.40"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.62 | - | 1.07 | - | 0.48 |
| 行业 | 1.02 | 0.00 | 1.46 | 0.00 | 1.40 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 6/110 ， 27/110。
[{"date":"2025-06-30","value":"2.12","vol":"2.88"},{"date":"2025-03-31","value":"2.02","vol":"2.97"},{"date":"2024-12-31","value":"2.12","vol":"2.86"},{"date":"2024-09-30","value":"2.22","vol":"3.22"},{"date":"2024-06-30","value":"2.09","vol":"2.95"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.12 | 2.02 | 2.12 | 2.22 | 2.09 |
| 行业 | 2.88 | 2.97 | 2.86 | 3.22 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.49","vol":"2.11"},{"date":"2025-03-31","value":"1.47","vol":"2.20"},{"date":"2024-12-31","value":"1.56","vol":"2.09"},{"date":"2024-09-30","value":"1.51","vol":"2.40"},{"date":"2024-06-30","value":"1.47","vol":"2.22"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.49 | 1.47 | 1.56 | 1.51 | 1.47 |
| 行业 | 2.11 | 2.20 | 2.09 | 2.40 | 2.22 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 13/110 ， 19/110。
[{"date":"2025-06-30","value":"42.14","vol":"33.91"},{"date":"2025-03-31","value":"42.76","vol":"33.34"},{"date":"2024-12-31","value":"40.67","vol":"34.08"},{"date":"2024-09-30","value":"36.77","vol":"32.93"},{"date":"2024-06-30","value":"37.51","vol":"33.75"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
42.14 | 42.76 | 40.67 | 36.77 | 37.51 |
| 行业(%) | 33.91 | 33.34 | 34.08 | 32.93 | 33.75 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.73","vol":"0.74"},{"date":"2025-03-31","value":"0.75","vol":"0.72"},{"date":"2024-12-31","value":"0.69","vol":"0.74"},{"date":"2024-09-30","value":"0.59","vol":"3.16"},{"date":"2024-06-30","value":"0.60","vol":"1.63"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.73 | 0.75 | 0.69 | 0.59 | 0.60 |
| 行业(%) | 0.74 | 0.72 | 0.74 | 3.16 | 1.63 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.35","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.18","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]